iRhythm Technologies, Inc. (IRTC)
Stock Price:
$190.09 USD
21.04 (12.45%)
Updated Aug 5, 2020 4:00 PM EDT - Market closed
After-hours: $190.00 -0.09 (-0.05%) Aug 5, 7:22 PM
Key Info
| Market Cap |
5.14B |
| Revenue (ttm) |
229.75M |
| Net Income (ttm) |
-56.13M |
| Shares Out |
27.04M |
| EPS (ttm) |
-2.14 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 5, 2020 |
| Last Price |
$190.09 |
| Previous Close |
$169.05 |
| Change ($) |
21.04 |
| Change (%) |
12.45% |
| Day's Open |
169.26 |
| Day's Range |
168.23 - 191.98 |
| Day's Volume |
1,407,948 |
| 52-Week Range |
56.24 - 191.98 |
More Stats
| Market Cap |
5.14B |
| Enterprise Value |
5.15B |
| Earnings Date (est) |
Aug 6, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
27.04M |
| Float |
26.78M |
| EPS (basic) |
-2.18 |
| EPS (diluted) |
-2.14 |
| FCF / Share |
-1.84 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
3.91M |
| Short Ratio |
11.74 |
| Short % of Float |
18.71% |
| Beta |
1.39 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
22.37 |
| PB Ratio |
27.24 |
| Revenue |
229.75M |
| Operating Income |
-56.48M |
| Net Income |
-56.13M |
| Free Cash Flow |
-49.36M |
| Net Cash |
-6.29M |
| Net Cash / Share |
-0.23 |
| Gross Margin |
70.54% |
| Operating Margin |
-24.58% |
| Profit Margin |
-24.30% |
| FCF Margin |
-21.48% |
| ROA |
-17.41% |
| ROE |
-63.40% |
| ROIC |
-16.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (9)
| Buy |
8 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$136.50*
(-28.19% downside)
Low
130
Current: $190.09
High
147
Target: 136.50
*Average 12-month price target from 6 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | 215 | 147 | 99.13 | 64.07 | 36.14 | 21.75 |
| Revenue Growth | 45.68% | 48.57% | 54.72% | 77.29% | 66.17% | - |
| Gross Profit | 162 | 108 | 70.93 | 43.19 | 21.44 | 11.16 |
| Operating Income | -54.76 | -45.69 | -27.59 | -15.58 | -21.63 | -14.77 |
| Net Income | -54.57 | -50.38 | -29.74 | -20.90 | -22.80 | -15.83 |
| Shares Outstanding | 25.27 | 23.89 | 22.63 | 5.29 | 1.38 | 1.31 |
| Earnings Per Share | -2.16 | -2.11 | -1.31 | -3.95 | -16.57 | -12.05 |
| Operating Cash Flow | -21.86 | -29.09 | -14.91 | -16.65 | -18.01 | -15.63 |
| Capital Expenditures | -20.46 | -5.18 | -3.56 | -2.76 | -1.79 | -0.54 |
| Free Cash Flow | -42.32 | -34.27 | -18.47 | -19.41 | -19.79 | -16.17 |
| Cash & Equivalents | 141 | 78.34 | 102 | 106 | 25.30 | 8.71 |
| Total Debt | 129 | 34.90 | 33.98 | 32.23 | 30.55 | 6.26 |
| Net Cash / Debt | 11.96 | 43.44 | 68.39 | 73.91 | -5.25 | 2.45 |
| Assets | 306 | 118 | 133 | 138 | 37.87 | 18.51 |
| Liabilities | 171 | 65.39 | 53.57 | 45.59 | 42.40 | 14.04 |
| Book Value | 135 | 52.14 | 79.55 | 92.56 | -102 | -80.54 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
iRhythm Technologies, Inc. |
| Country |
United States |
| Employees |
997 |
| CEO |
Kevin M. King |
Stock Information
| Ticker Symbol |
IRTC |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: IRTC |
| IPO Date |
October 20, 2016 |
Description
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.